Volume7, Issue0 (2021)

Volume

Table of Contents (156 articles)

Revisiting the role of the hepatic vein in laparoscopic liver resection

Daisuke Ban, ... Kazuaki Shimada

The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma

Zun-Yong Feng, ... Hong-Ping Xia

The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

Francesca D’Arcangelo, ... Patrizia Burra

The evolution of minimally invasive surgery in liver transplantation for hepatocellular carcinoma

Georgios S. Sioutas, ... Georgios Tsoulfas

Feasibility of totally laparoscopic hemi-hepatectomies for liver tumor, with consideration of correspondence for difficult cases

Yuichiro Otsuka, ... Hironori Kaneko

Immunological characterization of hepatocellular carcinoma

Sarah Ziqi Wang, ... Marlon F. Levy

Statistical strategies for HCC risk prediction models in patients with chronic hepatitis B

Terry Cheuk-Fung Yip, ... Grace Lai-Hung Wong

Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?

Antonio Salvati, ... Maurizia Rossana Brunetto

Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma

Samantha Armstrong, ... Aiwu Ruth He

Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease

Ramy Younes, ... Olivier Govaere

Liver regeneration: metabolic and epigenetic regulation

Sudhir Verma, ... Madan Mohan Chaturvedi

Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers

Sandi A. Kwee, ... Maarit Tiirikainen

Prevention of hepatitis B virus-related hepatocellular carcinoma

Chih-Lin Lin, ... Jia-Horng Kao

Involvement of DNA methylation in tissue regeneration upon liver injury

Loraine Kay D Cabral, ... Caecilia H C Sukowati

Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection

Yutaro Kato, ... Ichiro Uyama

From PVE to HVE to fully laparoscopic rescue ALPPS: a case report of multidisciplinary management of giant HCC

Valentina Malerba, ... Mohammed Abu Hilal

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

Jin Zhou, ... Paul M. Yen

Earliest hepatitis B virus-hepatocyte genome integration: sites, mechanism, and significance in carcinogenesis

Ranjit Chauhan, ... Tomasz I. Michalak

Prospects for a better diagnosis and prognosis of NAFLD: a pathologist´s view

Carolin Lackner

Optimize nucleot(s)ide analogues’ to prevent hepatocellular carcinoma in patients with chronic hepatitis B: a lesson from real-world evidence

Jihye Lim, ... Jonggi Choi

Laparoscopic ICG-guided RALPPS procedure for HCC on cirrhosis with 3D reconstruction implementation: a case report

Francesca Pegoraro, ... Roberto Ivan Troisi

Patient and port positioning in laparoscopic liver resections

Nita Thiruchelvam, ... Adrian Kah Heng Chiow

The impact of rituximab prophylaxis on hepatocellular carcinoma recurrence after living donor liver transplantation

Naoko Kamo, ... Shintaro Yagi

Coffee and hepatocellular carcinoma: epidemiologic evidence and biologic mechanisms

Filippo Pelizzaro, ... Fabio Farinati

Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease

Ling-Jia Gao, ... Liang Xu

Prevention of hepatitis B virus recurrence

James Fung

Extrahepatic cancer risk after liver transplantation for hepatocellular carcinoma: incidence, risk and prevention

Claire M. Vajdic, ... Geoffrey W. McCaughan

Risk factors and management of post-liver transplant recurrence of hepatocellular carcinoma

Ashwin Rammohan, ... Mohamed Rela

GNMT: a multifaceted suppressor of hepatocarcinogenesis

Maria M. SImile, ... Francesco Feo

Autoimmune liver diseases, hepatocellular carcinoma, and recurrence of autoimmunity post-liver transplantation

Sarah Wang, ... Andrew L. Mason

Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma

Ourania Andrisani

Implications of diameter and volume-based measurement in assessment criteria for liver transplantation for hepatocellular carcinoma

Alice I. Graham, ... Stephen J. Wigmore

Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

Pablo J. Giraudi, ... Natalia Rosso

Systematic review of existing guidelines for NAFLD assessment

Filippo Monelli, ... Giulia Besutti

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

Chimaobi M. Anugwom, ... Jose D. Debes

Effect of mesenchymal stem cell in liver regeneration and clinical applications

Seong Min Lee, ... Marlon F. Levy

Steatohepatitic hepatocellular carcinoma

Michael S. Torbenson, ... Mathew M. Yeh

Laparoscopic isolated caudate lobectomy for HCC

Tae-Seok Kim, ... Choon Hyuck David Kwon

The future of pediatric hepatocellular carcinoma: a combination of surgical, locoregional, and targeted therapy

Víola B. Weeda, ... Maciej Murawski

Immune checkpoint inhibitors in liver transplant recipients - a review of current literature

Chao Yin, ... Coleman Smith

Clinicoradiographic predictors of progression of an intermediate hepatic lesion (LI-RADS 3) to hepatocellular carcinoma (LI-RADS 5)

Lindsay M. Hannan, ... Puneet Bhargava

Use of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B

Won-Mook Choi, ... Jonggi Choi

Hepatocellular carcinoma in transfusion dependent thalassemia patients: a review from a clinical perspective

Nikolaos Papadopoulos, ... John Koskinas

Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Huiguo Ding, ...

Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa

Daniel Mak, ... Anna Kramvis

Contribution of C3G and other GEFs to liver cancer development and progression

Almudena Porras, ... Carmen Guerrero

Preoperative planning in paediatric liver tumour surgery - a literature review

Dominika Kościuszko, ... Piotr Czauderna

Bridging molecular basis, prognosis, and treatment of pediatric liver tumors

Carolina Armengol, ... Roland Kappler

The prognostic evaluation of marginal positive resection in hepatoblastoma: Japanese experience

Eiso Hiyama, ... Yukichi Tanaka

HCC in metabolic syndrome: current concepts and future directions

Lucia Zampaglione, ... Nicolas Goossens

Systemic therapies for hepatocellular carcinoma: an evolving landscape

Filippo Pelizzaro, ... Fabio Farinati

Surgical perspective on treatment of pediatric undifferentiated sarcoma of the liver

Ana M. Calinescu, ... Florent Guérin

A practical approach to pediatric liver transplantation in hepatoblastoma and hepatocellular carcinoma

Ana M. Calinescu, ... Sophie Branchereau

Neoplastic risk for liver and colon in primary sclerosing cholangitis

Aiva Lundberg Båve, ... Annika Bergquist

Defining the role of laparoscopic liver resection in elderly HCC patients: a propensity score matched analysis

Phoenix Wai Yan Wong, ... Chung Mau Lo

Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study

Gauri Mishra, ... Stuart K. Roberts

3D Organoid modelling of hepatoblast-like and mesenchymal-like hepatocellular carcinoma cell lines

Ozden Oz, ... Mehmet Ozturk

Role of CD4⁺T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

Takuya Seike, ... Shuichi Kaneko

Management of future liver remnant: strategies to promote hepatic hypertrophy

Toru Beppu, ... Shinichi Akahoshi

Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor

Diamantis I. Tsilimigras, ... Timothy M. Pawlik

The narrow ridge from liver damage to hepatocarcinogenesis

Jan Best, ... Guido Gerken

Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease

Tien S. Dong, ... Jonathan P. Jacobs

BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function

Gennaro Daniele, ... Bruno Daniele

From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: more than a single-letter change in an acronym

Giovanni Targher

Anatomic vs. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises?

Nicole M. Nevarez, ... Adam C. Yopp

Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes

Jihane N. Benhammou, ... Myron J. Tong

Evaluation of liver function before and during therapy

Matthias Buechter, ... Guido Gerken

Epigenetics in hepatoblastoma

Alex Clavería-Cabello, ... Matías A. Ávila

Treatment of advanced biliary tract cancers: from chemotherapy to targeted agents

Raffaella Casolino, ... Chiara Braconi

C-kit expression in cancer cells or hematopoietic cells of the tumoral microenvironment: which is the basis for efficacy of TK inhibitors and immunotherapy in HCC?

Giuliano Ramadori

Racial difference of mutational signature in hepatocellular carcinoma

Bai-Feng Zhang, ... Xin-Yuan Guan

The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD

Jin Zhou, ... Paul M. Yen

Surgical management of cholangiocarcinoma

D. Brock Hewitt, ... Timothy M. Pawlik

Neoadjuvant and adjuvant systemic treatment for hepatocellular carcinoma

Maria Cecilia Mathias-Machado, ... Leonardo G. da Fonseca

Adjuvant treatment of hepatocellular carcinoma after resection

Zachary J. Brown, ... Allan Tsung

Pathology and molecular pathology of cholangiocarcinoma

Federica Pedica, ... Greta Grassini

A review of current adjuvant and neoadjuvant systemic treatments for cholangiocarcinoma and gallbladder carcinoma

Michael J. Allen, ... Jennifer J. Knox

Non-invasive detection of liver cirrhosis - the “Essen algorithm”

Matthias Buechter, ... Guido Gerken

Clinicoradiographic predictors of progression of an intermediate hepatic lesion (LI-RADS 3) to hepatocellular carcinoma (LI-RADS 5)

Lindsay M. Hannan, ... Puneet Bhargava

Hepatocellular carcinoma in transfusion dependent thalassemia patients: a review from a clinical perspective

Nikolaos Papadopoulos, John Koskinas

Treatment of advanced biliary tract cancers: from chemotherapy to targeted agents

Raffaella Casolino, Chiara Braconi

Surgical management of cholangiocarcinoma

D. Brock Hewitt, ... Timothy M. Pawlik

Use of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B

Won-Mook Choi

, Jonggi Choi

A review of current adjuvant and neoadjuvant systemic treatments for cholangiocarcinoma and gallbladder carcinoma

Michael J. Allen, Jennifer J. Knox

The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD

Jin Zhou, ... Paul M. Yen

Pathology and molecular pathology of cholangiocarcinoma

Federica Pedica, Greta Grassini

Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes

Jihane N. Benhammou, ... Myron J. Tong

C-kit expression in cancer cells or hematopoietic cells of the tumoral microenvironment: which is the basis for efficacy of TK inhibitors and immunotherapy in HCC?

Giuliano Ramadori

Adjuvant treatment of hepatocellular carcinoma after resection

Zachary J. Brown, Allan Tsung

Neoadjuvant and adjuvant systemic treatment for hepatocellular carcinoma

Maria Cecilia Mathias-Machado, Leonardo G. da Fonseca

Anatomic vs. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises?

Nicole M. Nevarez, Adam C. Yopp

Epigenetics in hepatoblastoma

Alex Clavería-Cabello, ... Matías A. Ávila

Management of future liver remnant: strategies to promote hepatic hypertrophy

Toru Beppu, ... Shinichi Akahoshi

Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor

Diamantis I. Tsilimigras, Timothy M. Pawlik

Racial difference of mutational signature in hepatocellular carcinoma

Bai-Feng Zhang, Xin-Yuan Guan

Non-invasive detection of liver cirrhosis - the “Essen algorithm”

Matthias Buechter, Guido Gerken

BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function

Gennaro Daniele, ... Bruno Daniele

Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study

Gauri Mishra, ... Stuart K. Roberts

3D Organoid modelling of hepatoblast-like and mesenchymal-like hepatocellular carcinoma cell lines

Ozden Oz, ... Mehmet Ozturk

A practical approach to pediatric liver transplantation in hepatoblastoma and hepatocellular carcinoma

Ana M. Calinescu, ... Sophie Branchereau

Effect of mesenchymal stem cell in liver regeneration and clinical applications

Seong Min Lee, ... Marlon F. Levy

Risk factors and management of post-liver transplant recurrence of hepatocellular carcinoma

Ashwin Rammohan, Mohamed Rela

Evaluation of liver function before and during therapy

Matthias Buechter, Guido Gerken

HCC in metabolic syndrome: current concepts and future directions

Lucia Zampaglione, ... Nicolas Goossens

From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: more than a single-letter change in an acronym

Giovanni Targher

The future of pediatric hepatocellular carcinoma: a combination of surgical, locoregional, and targeted therapy

Víola B. Weeda, Maciej Murawski

Autoimmune liver diseases, hepatocellular carcinoma, and recurrence of autoimmunity post-liver transplantation

Sarah Wang, ... Andrew L. Mason

Involvement of DNA methylation in tissue regeneration upon liver injury

Loraine Kay D Cabral, ... Caecilia H C Sukowati

Neoplastic risk for liver and colon in primary sclerosing cholangitis

Aiva Lundberg Båve, Annika Bergquist

Immune checkpoint inhibitors in liver transplant recipients - a review of current literature

Chao Yin, ... Coleman Smith

Preoperative planning in paediatric liver tumour surgery - a literature review

Dominika Kościuszko, ... Piotr Czauderna

Bridging molecular basis, prognosis, and treatment of pediatric liver tumors

Carolina Armengol, ... Roland Kappler

Surgical perspective on treatment of pediatric undifferentiated sarcoma of the liver

Ana M. Calinescu

, ... Florent Guérin

The prognostic evaluation of marginal positive resection in hepatoblastoma: Japanese experience

Eiso Hiyama, ... Yukichi Tanaka

Role of CD4⁺T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

Takuya Seike, ... Shuichi Kaneko

Defining the role of laparoscopic liver resection in elderly HCC patients: a propensity score matched analysis

Phoenix Wai Yan Wong, ... Chung Mau Lo

Contribution of C3G and other GEFs to liver cancer development and progression

Almudena Porras

, ... Carmen Guerrero

Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa

Daniel Mak, Anna Kramvis

Steatohepatitic hepatocellular carcinoma

Michael S. Torbenson, Mathew M. Yeh

Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease

Tien S. Dong, ... Jonathan P. Jacobs

Systemic therapies for hepatocellular carcinoma: an evolving landscape

Filippo Pelizzaro, ... Fabio Farinati

GNMT: a multifaceted suppressor of hepatocarcinogenesis

Maria M. SImile, ... Francesco Feo

Extrahepatic cancer risk after liver transplantation for hepatocellular carcinoma: incidence, risk and prevention

Claire M. Vajdic, ... Geoffrey W. McCaughan

Prevention of hepatitis B virus recurrence

James Fung

The narrow ridge from liver damage to hepatocarcinogenesis

Jan Best, Guido Gerken

The impact of rituximab prophylaxis on hepatocellular carcinoma recurrence after living donor liver transplantation

Naoko Kamo, Shintaro Yagi

Laparoscopic isolated caudate lobectomy for HCC

Tae-Seok Kim, Choon Hyuck David Kwon

Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease

Ling-Jia Gao, ... Liang Xu

Coffee and hepatocellular carcinoma: epidemiologic evidence and biologic mechanisms

Filippo Pelizzaro, ... Fabio Farinati

Prospects for a better diagnosis and prognosis of NAFLD: a pathologist´s view

Carolin Lackner

The evolution of minimally invasive surgery in liver transplantation for hepatocellular carcinoma

Georgios S. Sioutas, Georgios Tsoulfas

Laparoscopic ICG-guided RALPPS procedure for HCC on cirrhosis with 3D reconstruction implementation: a case report

Francesca Pegoraro, ... Roberto Ivan Troisi

Systematic review of existing guidelines for NAFLD assessment

Filippo Monelli

, ... Giulia Besutti

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

Chimaobi M. Anugwom, ... Jose D. Debes

Patient and port positioning in laparoscopic liver resections

Nita Thiruchelvam

, ... Adrian Kah Heng Chiow

Optimize nucleot(s)ide analogues’ to prevent hepatocellular carcinoma in patients with chronic hepatitis B: a lesson from real-world evidence

Jihye Lim, Jonggi Choi

Earliest hepatitis B virus-hepatocyte genome integration: sites, mechanism, and significance in carcinogenesis

Ranjit Chauhan, Tomasz I. Michalak

From PVE to HVE to fully laparoscopic rescue ALPPS: a case report of multidisciplinary management of giant HCC

Valentina Malerba, ... Mohammed Abu Hilal

Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma

Samantha Armstrong, ... Aiwu Ruth He

Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Huiguo Ding, ... Specialist Committee of Cancer Prevention and Control of Chinese Preventive Medicine Association

Liver regeneration: metabolic and epigenetic regulation

Sudhir Verma, ... Madan Mohan Chaturvedi

Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease

Ramy Younes, ... Olivier Govaere

Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?

Antonio Salvati, ... Maurizia Rossana Brunetto

Revisiting the role of the hepatic vein in laparoscopic liver resection

Daisuke Ban

, ... Kazuaki Shimada

Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma

Ourania Andrisani

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

Jin Zhou, ... Paul M. Yen

Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection

Yutaro Kato

, ... Ichiro Uyama

Prevention of hepatitis B virus-related hepatocellular carcinoma

Chih-Lin Lin, Jia-Horng Kao

Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers

Sandi A. Kwee, Maarit Tiirikainen

Statistical strategies for HCC risk prediction models in patients with chronic hepatitis B

Terry Cheuk-Fung Yip, ... Grace Lai-Hung Wong

Immunological characterization of hepatocellular carcinoma

Sarah Ziqi Wang

, ... Marlon F. Levy

Feasibility of totally laparoscopic hemi-hepatectomies for liver tumor, with consideration of correspondence for difficult cases

Yuichiro Otsuka

, ... Hironori Kaneko

The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

Francesca D’Arcangelo, ... Patrizia Burra

The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma

Zun-Yong Feng, ... Hong-Ping Xia

Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

Pablo J. Giraudi

, ... Natalia Rosso

Implications of diameter and volume-based measurement in assessment criteria for liver transplantation for hepatocellular carcinoma

Alice I. Graham, ... Stephen J. Wigmore

Volume

Table of Contents (156 articles)

Revisiting the role of the hepatic vein in laparoscopic liver resection

The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma

The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

The evolution of minimally invasive surgery in liver transplantation for hepatocellular carcinoma

Feasibility of totally laparoscopic hemi-hepatectomies for liver tumor, with consideration of correspondence for difficult cases

Immunological characterization of hepatocellular carcinoma

Statistical strategies for HCC risk prediction models in patients with chronic hepatitis B

Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?

Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma

Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease

Liver regeneration: metabolic and epigenetic regulation

Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers

Prevention of hepatitis B virus-related hepatocellular carcinoma

Involvement of DNA methylation in tissue regeneration upon liver injury

Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection

From PVE to HVE to fully laparoscopic rescue ALPPS: a case report of multidisciplinary management of giant HCC

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

Earliest hepatitis B virus-hepatocyte genome integration: sites, mechanism, and significance in carcinogenesis

Prospects for a better diagnosis and prognosis of NAFLD: a pathologist´s view

Optimize nucleot(s)ide analogues’ to prevent hepatocellular carcinoma in patients with chronic hepatitis B: a lesson from real-world evidence

Laparoscopic ICG-guided RALPPS procedure for HCC on cirrhosis with 3D reconstruction implementation: a case report

Patient and port positioning in laparoscopic liver resections

The impact of rituximab prophylaxis on hepatocellular carcinoma recurrence after living donor liver transplantation

Coffee and hepatocellular carcinoma: epidemiologic evidence and biologic mechanisms

Mechanisms of protective effects of astaxanthin in nonalcoholic fatty liver disease

Prevention of hepatitis B virus recurrence

Extrahepatic cancer risk after liver transplantation for hepatocellular carcinoma: incidence, risk and prevention

Risk factors and management of post-liver transplant recurrence of hepatocellular carcinoma

GNMT: a multifaceted suppressor of hepatocarcinogenesis

Autoimmune liver diseases, hepatocellular carcinoma, and recurrence of autoimmunity post-liver transplantation

Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma

Implications of diameter and volume-based measurement in assessment criteria for liver transplantation for hepatocellular carcinoma

Novel high-throughput applications for NAFLD diagnostics and biomarker discovery

Systematic review of existing guidelines for NAFLD assessment

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

Effect of mesenchymal stem cell in liver regeneration and clinical applications

Steatohepatitic hepatocellular carcinoma

Laparoscopic isolated caudate lobectomy for HCC

The future of pediatric hepatocellular carcinoma: a combination of surgical, locoregional, and targeted therapy

Immune checkpoint inhibitors in liver transplant recipients - a review of current literature

Clinicoradiographic predictors of progression of an intermediate hepatic lesion (LI-RADS 3) to hepatocellular carcinoma (LI-RADS 5)

Use of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B

Hepatocellular carcinoma in transfusion dependent thalassemia patients: a review from a clinical perspective

Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa

Contribution of C3G and other GEFs to liver cancer development and progression

Preoperative planning in paediatric liver tumour surgery - a literature review

Bridging molecular basis, prognosis, and treatment of pediatric liver tumors

The prognostic evaluation of marginal positive resection in hepatoblastoma: Japanese experience

HCC in metabolic syndrome: current concepts and future directions

Systemic therapies for hepatocellular carcinoma: an evolving landscape

Surgical perspective on treatment of pediatric undifferentiated sarcoma of the liver

A practical approach to pediatric liver transplantation in hepatoblastoma and hepatocellular carcinoma

Neoplastic risk for liver and colon in primary sclerosing cholangitis

Defining the role of laparoscopic liver resection in elderly HCC patients: a propensity score matched analysis

Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: an Australian multicenter cohort study

3D Organoid modelling of hepatoblast-like and mesenchymal-like hepatocellular carcinoma cell lines

Role of CD4+ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

Management of future liver remnant: strategies to promote hepatic hypertrophy

Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor

The narrow ridge from liver damage to hepatocarcinogenesis

Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease

BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function

From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: more than a single-letter change in an acronym

Anatomic vs. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises?

Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes

Evaluation of liver function before and during therapy

Epigenetics in hepatoblastoma

Treatment of advanced biliary tract cancers: from chemotherapy to targeted agents

C-kit expression in cancer cells or hematopoietic cells of the tumoral microenvironment: which is the basis for efficacy of TK inhibitors and immunotherapy in HCC?

Racial difference of mutational signature in hepatocellular carcinoma

The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD

Surgical management of cholangiocarcinoma

Neoadjuvant and adjuvant systemic treatment for hepatocellular carcinoma

Adjuvant treatment of hepatocellular carcinoma after resection

Pathology and molecular pathology of cholangiocarcinoma

A review of current adjuvant and neoadjuvant systemic treatments for cholangiocarcinoma and gallbladder carcinoma

Non-invasive detection of liver cirrhosis - the “Essen algorithm”

Role of CD4⁺T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

Role of CD4⁺T-cells in the pathology of non-alcoholic fatty liver disease and related diseases